MCo-SST-01
General Information
DRACP ID DRACP00627
Peptide Name MCo-SST-01
Sequence CPKILKKCRRDSDCPGACICRYwKVCGSGSDGGV
Sequence Length 34
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Cancer targeted peptides
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
MCF-7 | Invasive breast carcinoma of no special type | Carcinoma | IC50>100 μM | MTT assay | 48h | 1 |
PC-3 | Prostate carcinoma | Carcinoma | IC50=85.44±0.08 μM | MTT assay | 48h | 1 |
HT-29 | Colon adenocarcinoma | Carcinoma | IC50=74.13±0.07 μM | MTT assay | 48h | 1 |
Hemolytic Activity Human red blood cells: no hemolytic activity(as show in Fig.4)
Normal (non-cancerous) Cytotoxicity HUVEC: IC50=17.12±0.05 μM
Target pigment epithelium-derived factor; somatostatin
Affinity Not available
Mechanism Not available
Nature Anticancer; Antitumor
Structure Information
Helicity Not available
Linear/Cyclic Cyclic
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification w=D-Tryptophane
Chiral Mix
Physicochemical Information
Formula C141H238N46O43S6
Absent amino acids EFHMNQTW
Common amino acids C
Mass 404690
Pl 8.62
Basic residues 7
Acidic residues 3
Hydrophobic residues 6
Net charge 4
Boman Index -6643
Hydrophobicity -30.88
Aliphatic Index 54.41
Half Life
/
Extinction Coefficient cystines 1865
Absorbance 280nm 56.52
Polar residues 15
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 27734947
Title Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy
Year 2016
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available